Related Experiment Video
Updated: Jul 31, 2025

In Vivo Imaging and Quantitation of the Host Angiogenic Response in Zebrafish Tumor Xenografts
Published on: August 14, 2019
Investigation of the Effects of Some Cardiovascular Drugs on Angiogenesis by Transgenic Zebrafish
Hui Lv1, Bo Liu2, Yongwen Qin3
1Department of Cardiovascular Disease, The Second Affiliated Hospital of Shanxi Medical University, Taiyuan, Shanxi 030001, China.
Introduction:
Angiogenesis contributes to the pathophysiology of cardiovascular disease (CVD). Some cardiovascular drugs used in the treatment of CVD have an effect on the process of angiogenesis.
Methods:
Transgenic Tg (flk1: EGFP) zebrafish embryos were used to identify the effects of some cardiovascular drugs on angiogenesis during vertebral development in vivo. Zebrafish embryos at a one-cell stage or two-cell stage were cultured with embryo medium containing cardiovascular drugs at a final solvent concentration of 0.5% (V/V) dimethyl sulfoxide (DMSO) for 24 hours in 24-well plates.
Results:
We found that 6 drugs including isosorbide mononitrate, amlodipine, bisoprolol fumarate, carvedilol, irbesartan, and rosuvastatin calcium may affect angiogenesis by vascular endothelial growth factor (VEGF) signaling pathway.
Conclusion:
These new findings of some cardiovascular drugs should improve the treatment of cardiovascular diseases.
Insights
Cardiovascular drugs like isosorbide mononitrate and rosuvastatin calcium may impact blood vessel formation (angiogenesis) via the VEGF pathway, potentially improving cardiovascular disease treatment.
Area of Science:
- Cardiovascular Research
- Developmental Biology
- Pharmacology
Background:
- Angiogenesis is integral to cardiovascular disease (CVD) pathophysiology.
- Certain cardiovascular drugs influence angiogenesis.
Purpose of the Study:
- To investigate the in vivo effects of cardiovascular drugs on angiogenesis during vertebral development.
- To identify specific cardiovascular drugs that modulate angiogenesis.
Main Methods:
- Utilized transgenic Tg (flk1: EGFP) zebrafish embryos for in vivo angiogenesis studies.
- Exposed zebrafish embryos to cardiovascular drugs in embryo medium with 0.5% DMSO for 24 hours.
Main Results:
- Identified six drugs affecting angiogenesis: isosorbide mononitrate, amlodipine, bisoprolol fumarate, carvedilol, irbesartan, and rosuvastatin calcium.
- These drugs potentially influence angiogenesis through the vascular endothelial growth factor (VEGF) signaling pathway.
Conclusions:
- Findings suggest specific cardiovascular drugs can modulate angiogenesis.
- These insights may lead to improved therapeutic strategies for cardiovascular diseases.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Mechanism of Angiogenesis

